Jashvik Capital Makes Strategic Investment in Rivarp

Jashvik Capital announced its portfolio company Futura Medtech invested strategically in Bengaluru‑based medical device maker Rivarp Medical.
This marks the third investment under the Futura Medtech platform, following Dolphin Sutures (Oct 2024) and Suture Planet (Jul 2025).
Rivarp Medical, founded 2016, offers orthopaedic, neurosurgery and interventional cardiology implants with EU MDR and US FDA approvals and 100+ channel partners.
Jashvik plans further investments over the next two years to expand product basket, innovation pipeline and distribution reach across India and abroad.